News Erythropoietin Falls Short of Neuroprotection in Optic Neuritis by Medscape • 2021/03/04 • 0 Comments A higher rate of conversion to multiple sclerosis in the placebo group offered a glimmer of hope for treatment in TONE, a phase 3 randomized trial, but caveats loom large. Medscape Medical News Full Story →